Similar experiments were performed in the tumor xenografts developed from shRNA-Ctr/HT-29, shRNA-Ascl2/HT-29 cells, shRNA-Ctr/LS174T or shRNA-Ascl2/LS174T cells. This evidence concerns the gene ASCL2 and neoplasm.